Market Place
Sourcing Support
EU Moment of Truth For Abaloparatide & Advanced Therapy Tab-Cel
11 Oct 2022 //
PHARMAINTELLIGENCE
Quince Presents Data Demonstrating Application of Bone-targeting Platform
12 Sep 2022 //
BUSINESSWIRE
FDA Confirms Paragraph IV Patent Litigation for Tymlos (Abaloparatide)
24 Aug 2022 //
FDA
Menarini Group’s Elacestrant Granted Priority Review by the U.S. FDA
11 Aug 2022 //
BUSINESSWIRE
2 investment firms buy Radius, bone drug Tymlos for $890M
24 Jun 2022 //
FIERCEPHARMA
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.